Skip to content
10-Q

Quarterly Report

Cellectar Biosciences, Inc. CLRB

0001410578-25-001778

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 12, 2025 3.19M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.61M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.57M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.25M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 1.09M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$14.5M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$27.5M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $11.04M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $23.29M
Stockholders Equity Q2 2025 · Jun 30, 2025 $6.09M
Stockholders Equity Q2 2025 · Mar 31, 2025 $8.25M
Stockholders Equity Q2 2025 · Dec 31, 2024 $14.29M
Stockholders Equity Q2 2025 · Jun 30, 2024 $12.38M
Stockholders Equity Q2 2025 · Mar 31, 2024 $12.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$15.16M
Current Liabilities Q2 2025 · Jun 30, 2025 $5.87M
Current Liabilities Q2 2025 · Dec 31, 2024 $9.39M
Total Liabilities Q2 2025 · Jun 30, 2025 $6.23M
Total Liabilities Q2 2025 · Dec 31, 2024 $9.8M
Current Assets Q2 2025 · Jun 30, 2025 $12.62M
Current Assets Q2 2025 · Dec 31, 2024 $24.25M
Total Assets Q2 2025 · Jun 30, 2025 $13.7M
Total Assets Q2 2025 · Dec 31, 2024 $25.47M
Eps Diluted Q2 2025 · Jun 30, 2025 −$3.39
Eps Diluted Q2 2025 · Jun 30, 2025 −$7.66
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$5.43
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$25.38
Eps Basic Q2 2025 · Jun 30, 2025 −$3.39
Eps Basic Q2 2025 · Jun 30, 2025 −$7.66
Eps Basic restated Q2 2025 · Jun 30, 2024 −$0.77
Eps Basic restated Q2 2025 · Jun 30, 2024 −$25.38
Sga Expense Q2 2025 · Jun 30, 2025 $3.65M
Sga Expense Q2 2025 · Jun 30, 2025 $6.62M
Sga Expense Q2 2025 · Jun 30, 2024 $6.36M
Sga Expense Q2 2025 · Jun 30, 2024 $11.27M
Rd Expense Q2 2025 · Jun 30, 2025 $2.39M
Rd Expense Q2 2025 · Jun 30, 2025 $5.82M
Rd Expense Q2 2025 · Jun 30, 2024 $7.35M
Rd Expense Q2 2025 · Jun 30, 2024 $14.43M
Net Income Q2 2025 · Jun 30, 2025 −$5.45M
Net Income Q2 2025 · Jun 30, 2025 −$12.05M
Net Income Q2 2025 · Mar 31, 2025 −$6.6M
Net Income Q2 2025 · Jun 30, 2024 −$919.37K
Net Income Q2 2025 · Jun 30, 2024 −$27.56M
Net Income Q2 2025 · Mar 31, 2024 −$26.64M
Operating Income Q2 2025 · Jun 30, 2025 −$6.04M
Operating Income Q2 2025 · Jun 30, 2025 −$12.44M
Operating Income Q2 2025 · Jun 30, 2024 −$13.7M
Operating Income Q2 2025 · Jun 30, 2024 −$25.71M
Capex Q2 2025 · Jun 30, 2024 $42.91K